Furthermore, studies have reported that the promoting effect of IL-22 on CRC development occurs through the activation of STAT-3 (137), and neutralizing both IL-22 and STAT-3 signals reduces tumorigenesis in vivo and in vitro (61). This evidence concerns the gene STAT3 and colorectal carcinoma.